Fuller & Thaler Asset Management
DGX icon

Fuller & Thaler Asset Management’s Quest Diagnostics DGX Stock Holding History

Fuller & Thaler Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.7M Buy
31,605
+6,683
+27% +$1.31M 0.02% 327
2026
Q1 		$4.88M Buy
24,922
+5,360
+27% +$1.04M 0.02% 331
2025
Q4 		$3.39M Buy
19,562
+5,362
+38% +$976K 0.01% 343
2025
Q3 		$2.71M Sell
14,200
-296
-2% -$52.5K 0.01% 356
2025
Q2 		$2.6M Buy
14,496
+1,135
+8% +$197K 0.01% 361
2025
Q1 		$2.26M Sell
13,361
-10,461
-44% -$1.72M 0.01% 360
2024
Q4 		$3.59M Buy
23,822
+2,445
+11% +$380K 0.01% 339
2024
Q3 		$3.32M Buy
21,377
+4,056
+23% +$606K 0.01% 332
2024
Q2 		$2.37M Buy
17,321
+5,050
+41% +$692K 0.01% 360
2024
Q1 		$1.63M Buy
12,271
+2,428
+25% +$315K 0.01% 389
2023
Q4 		$1.36M Buy
9,843
+3,198
+48% +$420K 0.01% 384
2023
Q3 		$810K Buy
6,645
+600
+10% +$79.9K ﹤0.01% 395
2023
Q2 		$850K Buy
6,045
+1,415
+31% +$195K ﹤0.01% 400
2023
Q1 		$655K Buy
4,630
+4,545
+5,347% +$650K ﹤0.01% 401
2022
Q4 		$13K Buy
+85
New +$12.2K ﹤0.01% 458
2018
Q3 		– Sell
-900
Closed -$99K – 533
2018
Q2 		$99K Hold
900
– – ﹤0.01% 524
2018
Q1 		$90K Sell
900
-300
-25% -$30.7K ﹤0.01% 550
2017
Q4 		$118K Buy
+1,200
New +$114K ﹤0.01% 493
2016
Q3 		– Sell
-1,000
Closed -$81K – 772
2016
Q2 		$81K Hold
1,000
– – ﹤0.01% 513
2016
Q1 		$71K Sell
1,000
-1,300
-57% -$87.2K ﹤0.01% 474
2015
Q4 		$164K Sell
2,300
-1,000
-30% -$67.2K ﹤0.01% 407
2015
Q3 		$203K Buy
+3,300
New +$231K 0.01% 390
2013
Q3 		– Sell
-1,200
Closed -$73K – 662
2013
Q2 		$73K Buy
+1,200
New +$71.5K 0.01% 534

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Fuller & Thaler Asset Management's DGX Position: Q2 2026 in Review

Fuller & Thaler Asset Management increased its Quest Diagnostics (DGX) stake by 27% in Q2 2026, buying an estimated $1.31M and bringing the position to 31,605 shares worth $6.7M. The position accounts for 0.02% of the portfolio, ranked #327.

Fuller & Thaler Asset Management first reported a position in DGX in Q2 2013 and has held it in 23 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Fuller & Thaler Asset Management held 31,605 shares of Quest Diagnostics worth $6.7M as of Q2 2026.
  • Fuller & Thaler Asset Management bought 6,683 Quest Diagnostics shares in Q2 2026, an estimated $1.31M.
  • Quest Diagnostics made up 0.02% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #327 holding.
  • Fuller & Thaler Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 23 quarters since.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.